Value | |
---|---|
No. of subjects | 97 |
Mean age (yr) | 60.2 (SD, 16) |
Sex (F/M) | 48:49 |
Clinical indication for MR imaging (No.) (%) | |
Tumor | 32 (33%) |
Stroke | 17 (17.5%) |
AMS | 15 (15.4%) |
Neurologic deficit | 11 (11.3%) |
Abscess | 3 (3%) |
Dementia | 2 (2%) |
Headache | 2 (2%) |
Seizure | 2 (2%) |
TBI | 2 (2%) |
TIA | 2 (2%) |
Other | 9 (9.2%) |
MR imaging protocol (No.) (%) | |
SAMER MPRAGE without contrast | 34 (35%) |
Routine brain without contrast | 33 (34%) |
Memory loss without contrast | 1 (1%) |
SAMER MPRAGE with contrast | 63 (65%) |
Routine brain without and with contrast | 61 (63%) |
Memory loss without and with contrast | 2 (2%) |
Note:—AMS indicates altered mental status; TBI, traumatic brain injury.